Skip to content


A new treatment for maculopathies and age-related macular degeneration.

  • What is it?

    is a patented ophthalmic treatment: a new method of administering lutein topically called scleral iontophoresis. Lutein is a natural substance that protects the eye from the negative effects of light and photo-oxidative damage while improving visual function.

  • When is the treatment performed?

    is a topical supplementation treatment that can be performed when supporting the treatment of age-related macular degeneration.

  • How is the treatment performed?

    The treatment is outpatient, lasts only a few minutes, is performed directly by your ophthalmologist and consists of administering lutein into the macula using a special disposable applicator.

Age-Related Macular Degeneration Prevention Guide

Age-Related Macular Degeneration (AMD) is a condition that can severely impair your central vision.

Learn more about pathology

What is AMD?

AMD is an age-related condition that affects the macula, the area of your eye that allows you to see fine details. It is the leading cause of vision loss over the age of 50.

How does it manifest itself?

Symptoms of AMD may include distortion of straight lines and dark spots in the central vision. If you notice these signs, it is essential to consult an ophthalmologist.

Early Diagnosis

Regular eye examinations and the Amsler Test are essential after the age of 50 to detect AMD early and maintain retinal health.

For more info

Contact your eye doctor of choice, share our page with him and follow his advice.

Share our page